Learn more about customized services for your metabolic drug or device clinical development programs.

contact us

Browse Scientific Publications

Obesity Fact Sheet View our Obesity Drug Development Fact Sheet



Experts in Obesity Clinical Research

We work with clients worldwide to design customized, scalable clinical research programs for obesity-related drug candidates. Our clinical research expertise in obesity and related co-morbidities spans 17 years, as does our scientific and medical understanding of the disease pathology and methods to assess body composition, body fat distribution, food intake, energy metabolism and adipose tissue function.

Our Obesity Compound Experience – A Few Examples:

  • DGAT inhibitors
  • GLP-1 agonists
  • Leptin agonists
  • FGF21 analogs
  • Centrally acting small molecule appetite suppressants
  • Peptide YY
  • Amylin agonists
  • Dual incretin agonists
  • Antipsychotics